|
English
|
正體中文
|
简体中文
|
2826201
|
|
???header.visitor??? :
31828734
???header.onlineuser??? :
1312
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"gish r"???jsp.browse.items-by-author.description???
Showing items 1-5 of 5 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2021-07-03T03:33:41Z |
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop
|
Block T.M.; Alter H.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.F.; Guo J.-T.; Hoshida Y.; Kowdley K.V.; Li W.; Lok A.S.; McMahon B.; Mehta A.; Perrillo R.; Rice C.M.; Rinaudo J.; Schinazi R.F.; Shetty K. |
臺大學術典藏 |
2021-07-03T03:33:40Z |
A research agenda for curing chronic hepatitis B virus infection
|
Alter H.; Block T.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Chisari F.V.; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.; Guo H.; Guo J.-T.; Hoshida Y.; Hu J.; Kowdley K.V.; Li W.; Liang J.; Locarnini S.; Lok A.S.; Mason W.; McMahon B.; Mehta A.; Perrillo R.; Revill P.; Rice C.M.; Rinaudo J.; Schinazi R.; Seeger C.; Shetty K.; Tavis J.; Zoulim F. |
國立成功大學 |
2012-09 |
Entecavir efficacy and safety in patients >= 50 years of age
|
Sievert, W.; Wedemeyer, H.; Gish, R.; Nguyen, T.; Lai, C. L.; Llamoso, C.; Chang, T. T. |
國立成功大學 |
2009 |
Loss of HBsAg Antigen During Treatment With Entecavir in Nucleoside-na�ve HBeAg-positive Patients With Chronic Hepatitis B
|
Gish, R.; Chang, Ting-Tsung; Lai, C. L.; Man, R.; Gadano, A.; Poordad, F.; Yang, J.; Tamez, R.; Brett Smith H. |
國立成功大學 |
2006-07 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
De Man, R. A.; Mutimer, D.; Gish, R.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
Showing items 1-5 of 5 (1 Page(s) Totally) 1 View [10|25|50] records per page
|